サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1150349

不眠症の世界市場規模・シェア・産業動向分析レポート：流通チャネル別（病院、小売、その他）、治療タイプ別（薬理、非薬理）、地域別展望・予測、2022年～2028年

Global Insomnia Market Size, Share & Industry Trends Analysis Report By Distribution Channel (Hospital, Retail, and Others), By Therapy Type (Pharmacological and Non-Pharmacological), By Regional Outlook and Forecast, 2022 - 2028
出版日: | 発行: KBV Research | ページ情報: 英文 149 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
不眠症の世界市場規模・シェア・産業動向分析レポート：流通チャネル別（病院、小売、その他）、治療タイプ別（薬理、非薬理）、地域別展望・予測、2022年～2028年
出版日: 2022年09月30日
発行: KBV Research
ページ情報: 英文 149 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

不眠症の世界市場規模は、予測期間中にCAGR3.9％で成長し、2028年には57億米ドルに達すると予測されます。

不眠症市場は、仕事に関連するストレスの増加により拡大しています。仕事量の増加や過酷な勤務スケジュールにより、睡眠不足に陥ってしまうのです。さらに、警備員を含む多くの人が変則的なシフトで働いており、製造業は24時間体制で営業しています。このような不規則な勤務シフトによって、睡眠の質やリズムが影響を受けているのです。また、ここ数年、睡眠診断や不眠症の人のためのセンターが増加しています。不眠症のためのセンターは、人々がより質の高い睡眠を得るのを助け、睡眠障害のためのセンターは、診断検査施設として活用されています。

COVID-19インパクト分析

COVID-19の発生は、不眠症治療薬の市場拡大に恩恵をもたらすと予想されます。COVID-19の大流行により産業が機能しなくなり、多くの労働者が職を失い、社会のストレスレベルが上昇する要因となっています。また、パンデミックへの恐怖からうつ病を発症する人もいました。その結果、COVID-19の大流行により、ストレスやうつ病に起因する不眠症の発生が増加し、不眠症治療薬の需要が高まり、市場の拡大が見込まれています。

市場の成長要因

高齢化人口の増加

高齢者（65歳以上）は、若年者に比べ、ある種のがんを発症するリスクが11倍も高いという研究報告があります。今後20年間、世界人口の高齢化に伴い、高齢者のがん罹患率は増加すると予想されています。屈折異常、白内障、睡眠の問題、難聴などは、すべて高齢者にかなり多く見られます。世界的に見ても、高齢者の多くが睡眠の問題を抱えています。したがって、高齢化社会の進展は、不眠症の症例数の増加をもたらし、予測期間中の不眠症市場の成長をさらに後押しするものと思われます。

ヘルスケアコストの増加

医療費の増加や、治療オプションに対する認識向上による疾病の早期診断が、予測期間中の市場成長を促進する要因として予測されています。各国政府がヘルスケア産業に投資する資金の規模や数が増加していることも、市場成長の主要な要因の1つとなっています。COVID-19の大流行が始まると、多くの国の政府がヘルスケアシステムの構築への投資を強化しました。パンデミックの影響が小さくなるにつれ、さまざまな病院がこれらのリソースを他の深刻な病気の治療に集中させるようになっています。不眠症の市場は、ヘルスケアへの投資拡大により拡大しています。

市場抑制要因

不眠症の診断・治療費用の高さ

不眠症の診断や治療にかかる費用が高いことは、不眠症市場の成長を阻害する大きな要因のひとつです。また、「睡眠障害」という言葉は、個人の健康に重大な悪影響を及ぼし、高い社会的コストを発生させる様々な病気を含んでいます。不眠症になると、日常生活を送ることが困難になり、経済的・医療的負担が大きく、多くの患者は完全に身体障害者となります。不眠症の患者は、症状のない対照群と比較して、年間約2倍の医療費を直接的に費やしています。不眠症の市場は、薬価が高いため拡大していないです。

流通チャネル別の展望

不眠症治療薬の市場は、流通チャネル別に病院、小売、その他に分類されます。2021年の不眠症市場では、小売セグメントがかなりの売上シェアを記録しました。このセグメントの市場は、様々な小売店で睡眠障害治療用の錠剤が広く入手できるようになった結果、成長しています。さらに、不眠症のような病気の結果に対する意識の高まりも、この市場を成長させています。また、政府もこのような店舗で販売される睡眠障害治療薬を支援しています。

治療法のタイプ別展望

不眠症市場は、治療法の種類に基づいて、非薬理学的療法、薬理学的療法に区分されます。2021年には、薬理学的療法分野が不眠症市場を独占し、最大の収益シェアを占めました。これは、不眠症の有病率の上昇と、不眠症の治療薬の大手メーカーが増加していることに起因します。不眠症治療薬や睡眠薬の存在感は世界中に広がっています。この分野では、世界中に多くの市場関係者が存在するため、市場規模が拡大しています。

地域別の概況

地域別では、不眠症市場は北米、欧州、アジア太平洋、LAMEAで分析されています。2021年、北米地域は不眠症市場において最も高い収益シェアを占めました。これは、不眠症の有病率の増加、職場でのストレスの多発、同地域における不眠症センターの存在など、ヘルスケアシステムの発達に起因するものです。また、慢性腎臓病を患う患者数の増加や、この地域に相当数の不眠症クリニックが存在することも、市場の成長を促進すると予測されます。

目次

第1章 市場の範囲と調査手法

  • 市場の定義
  • 目的
  • 市場規模
  • セグメンテーション
    • 不眠症の世界市場、流通チャネル別
    • 不眠症の世界市場、治療法タイプ別
    • 不眠症の世界市場、地域別
  • 調査手法

第2章 市場概要

  • イントロダクション
    • 概要説明
      • 市場の構成とシナリオ
  • 市場に影響を与える主な要因
    • 市場促進要因
    • 市場の抑制要因

第3章 不眠症市場で展開されている戦略

第4章 不眠症の世界市場：流通チャネル別

  • 病院の世界市場：地域別
  • 小売の世界市場：地域別
  • 世界の地域別その他市場

第5章 不眠症の世界市場：治療タイプ別

  • 薬物療法の世界市場：地域別
  • 非薬理療法の世界市場：地域別

第6章 不眠症の世界市場：地域別

  • 北米
    • 北米の不眠症の国別市場
      • 米国
      • カナダ
      • メキシコ
      • 北米以外の地域
  • 欧州
    • 欧州の不眠症市場：国別
      • ドイツ
      • 英国
      • フランス
      • ロシア
      • スペイン
      • イタリア
      • その他欧州
  • アジア太平洋地域
    • アジア太平洋地域の不眠症の国別市場
      • 中国
      • 日本
      • インド
      • 韓国
      • シンガポール
      • マレーシア
      • その他アジア太平洋地域
  • LAMEA
    • LAMEAの不眠症市場：国別
      • ブラジル
      • アルゼンチン
      • UAE
      • サウジアラビア
      • 南アフリカ共和国
      • ナイジェリア
      • その他のLAMEA

第7章 企業プロファイル

  • Eisai Co., Ltd.
  • Takeda Pharmaceutical Company Limited
  • Vanda Pharmaceuticals, Inc.
  • Cadila Healthcare Ltd.（Zydus Cadila）
  • Sanofi S.A
  • Merck Group
  • Pfizer, Inc.
  • Viatris, Inc.
  • Currax Pharmaceuticals LLC（Currax Holdings USA LLC）
  • Purdue Pharma L.P
図表

LIST OF TABLES

  • TABLE 1 Global Insomnia Market, 2018 - 2021, USD Million
  • TABLE 2 Global Insomnia Market, 2022 - 2028, USD Million
  • TABLE 3 Global Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 4 Global Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 5 Global Hospital Market by Region, 2018 - 2021, USD Million
  • TABLE 6 Global Hospital Market by Region, 2022 - 2028, USD Million
  • TABLE 7 Global Retail Market by Region, 2018 - 2021, USD Million
  • TABLE 8 Global Retail Market by Region, 2022 - 2028, USD Million
  • TABLE 9 Global Others Market by Region, 2018 - 2021, USD Million
  • TABLE 10 Global Others Market by Region, 2022 - 2028, USD Million
  • TABLE 11 Global Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 12 Global Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 13 Global Pharmacological Market by Region, 2018 - 2021, USD Million
  • TABLE 14 Global Pharmacological Market by Region, 2022 - 2028, USD Million
  • TABLE 15 Global Non-Pharmacological Market by Region, 2018 - 2021, USD Million
  • TABLE 16 Global Non-Pharmacological Market by Region, 2022 - 2028, USD Million
  • TABLE 17 Global Insomnia Market by Region, 2018 - 2021, USD Million
  • TABLE 18 Global Insomnia Market by Region, 2022 - 2028, USD Million
  • TABLE 19 North America Insomnia Market, 2018 - 2021, USD Million
  • TABLE 20 North America Insomnia Market, 2022 - 2028, USD Million
  • TABLE 21 North America Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 22 North America Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 23 North America Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 24 North America Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 25 North America Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 26 North America Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 27 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 30 North America Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 31 North America Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 34 North America Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 35 North America Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 37 US Insomnia Market, 2018 - 2021, USD Million
  • TABLE 38 US Insomnia Market, 2022 - 2028, USD Million
  • TABLE 39 US Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 40 US Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 41 US Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 42 US Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 43 Canada Insomnia Market, 2018 - 2021, USD Million
  • TABLE 44 Canada Insomnia Market, 2022 - 2028, USD Million
  • TABLE 45 Canada Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 46 Canada Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 47 Canada Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 48 Canada Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 49 Mexico Insomnia Market, 2018 - 2021, USD Million
  • TABLE 50 Mexico Insomnia Market, 2022 - 2028, USD Million
  • TABLE 51 Mexico Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 52 Mexico Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 53 Mexico Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 54 Mexico Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 55 Rest of North America Insomnia Market, 2018 - 2021, USD Million
  • TABLE 56 Rest of North America Insomnia Market, 2022 - 2028, USD Million
  • TABLE 57 Rest of North America Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 58 Rest of North America Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 59 Rest of North America Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 60 Rest of North America Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 61 Europe Insomnia Market, 2018 - 2021, USD Million
  • TABLE 62 Europe Insomnia Market, 2022 - 2028, USD Million
  • TABLE 63 Europe Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 64 Europe Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 65 Europe Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 66 Europe Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 67 Europe Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 68 Europe Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 69 Europe Others Market by Country, 2018 - 2021, USD Million
  • TABLE 70 Europe Others Market by Country, 2022 - 2028, USD Million
  • TABLE 71 Europe Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 72 Europe Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 73 Europe Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 74 Europe Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 75 Europe Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 76 Europe Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 77 Europe Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 78 Europe Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 79 Germany Insomnia Market, 2018 - 2021, USD Million
  • TABLE 80 Germany Insomnia Market, 2022 - 2028, USD Million
  • TABLE 81 Germany Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 82 Germany Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 83 Germany Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 84 Germany Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 85 UK Insomnia Market, 2018 - 2021, USD Million
  • TABLE 86 UK Insomnia Market, 2022 - 2028, USD Million
  • TABLE 87 UK Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 88 UK Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 89 UK Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 90 UK Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 91 France Insomnia Market, 2018 - 2021, USD Million
  • TABLE 92 France Insomnia Market, 2022 - 2028, USD Million
  • TABLE 93 France Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 94 France Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 95 France Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 96 France Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 97 Russia Insomnia Market, 2018 - 2021, USD Million
  • TABLE 98 Russia Insomnia Market, 2022 - 2028, USD Million
  • TABLE 99 Russia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 100 Russia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 101 Russia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 102 Russia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 103 Spain Insomnia Market, 2018 - 2021, USD Million
  • TABLE 104 Spain Insomnia Market, 2022 - 2028, USD Million
  • TABLE 105 Spain Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 106 Spain Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 107 Spain Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 108 Spain Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 109 Italy Insomnia Market, 2018 - 2021, USD Million
  • TABLE 110 Italy Insomnia Market, 2022 - 2028, USD Million
  • TABLE 111 Italy Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 112 Italy Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 113 Italy Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 114 Italy Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 115 Rest of Europe Insomnia Market, 2018 - 2021, USD Million
  • TABLE 116 Rest of Europe Insomnia Market, 2022 - 2028, USD Million
  • TABLE 117 Rest of Europe Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 118 Rest of Europe Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 119 Rest of Europe Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 120 Rest of Europe Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 121 Asia Pacific Insomnia Market, 2018 - 2021, USD Million
  • TABLE 122 Asia Pacific Insomnia Market, 2022 - 2028, USD Million
  • TABLE 123 Asia Pacific Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 124 Asia Pacific Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 125 Asia Pacific Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 126 Asia Pacific Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 127 Asia Pacific Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 128 Asia Pacific Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 129 Asia Pacific Others Market by Country, 2018 - 2021, USD Million
  • TABLE 130 Asia Pacific Others Market by Country, 2022 - 2028, USD Million
  • TABLE 131 Asia Pacific Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 132 Asia Pacific Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 133 Asia Pacific Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 134 Asia Pacific Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 135 Asia Pacific Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 136 Asia Pacific Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 137 Asia Pacific Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 138 Asia Pacific Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 139 China Insomnia Market, 2018 - 2021, USD Million
  • TABLE 140 China Insomnia Market, 2022 - 2028, USD Million
  • TABLE 141 China Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 142 China Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 143 China Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 144 China Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 145 Japan Insomnia Market, 2018 - 2021, USD Million
  • TABLE 146 Japan Insomnia Market, 2022 - 2028, USD Million
  • TABLE 147 Japan Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 148 Japan Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 149 Japan Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 150 Japan Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 151 India Insomnia Market, 2018 - 2021, USD Million
  • TABLE 152 India Insomnia Market, 2022 - 2028, USD Million
  • TABLE 153 India Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 154 India Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 155 India Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 156 India Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 157 South Korea Insomnia Market, 2018 - 2021, USD Million
  • TABLE 158 South Korea Insomnia Market, 2022 - 2028, USD Million
  • TABLE 159 South Korea Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 160 South Korea Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 161 South Korea Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 162 South Korea Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 163 Singapore Insomnia Market, 2018 - 2021, USD Million
  • TABLE 164 Singapore Insomnia Market, 2022 - 2028, USD Million
  • TABLE 165 Singapore Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 166 Singapore Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 167 Singapore Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 168 Singapore Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 169 Malaysia Insomnia Market, 2018 - 2021, USD Million
  • TABLE 170 Malaysia Insomnia Market, 2022 - 2028, USD Million
  • TABLE 171 Malaysia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 172 Malaysia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 173 Malaysia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 174 Malaysia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 175 Rest of Asia Pacific Insomnia Market, 2018 - 2021, USD Million
  • TABLE 176 Rest of Asia Pacific Insomnia Market, 2022 - 2028, USD Million
  • TABLE 177 Rest of Asia Pacific Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 178 Rest of Asia Pacific Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 179 Rest of Asia Pacific Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 180 Rest of Asia Pacific Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 181 LAMEA Insomnia Market, 2018 - 2021, USD Million
  • TABLE 182 LAMEA Insomnia Market, 2022 - 2028, USD Million
  • TABLE 183 LAMEA Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 184 LAMEA Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 185 LAMEA Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 186 LAMEA Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 187 LAMEA Retail Market by Country, 2018 - 2021, USD Million
  • TABLE 188 LAMEA Retail Market by Country, 2022 - 2028, USD Million
  • TABLE 189 LAMEA Others Market by Country, 2018 - 2021, USD Million
  • TABLE 190 LAMEA Others Market by Country, 2022 - 2028, USD Million
  • TABLE 191 LAMEA Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 192 LAMEA Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 193 LAMEA Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 194 LAMEA Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 195 LAMEA Non-Pharmacological Market by Country, 2018 - 2021, USD Million
  • TABLE 196 LAMEA Non-Pharmacological Market by Country, 2022 - 2028, USD Million
  • TABLE 197 LAMEA Insomnia Market by Country, 2018 - 2021, USD Million
  • TABLE 198 LAMEA Insomnia Market by Country, 2022 - 2028, USD Million
  • TABLE 199 Brazil Insomnia Market, 2018 - 2021, USD Million
  • TABLE 200 Brazil Insomnia Market, 2022 - 2028, USD Million
  • TABLE 201 Brazil Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 202 Brazil Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 203 Brazil Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 204 Brazil Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 205 Argentina Insomnia Market, 2018 - 2021, USD Million
  • TABLE 206 Argentina Insomnia Market, 2022 - 2028, USD Million
  • TABLE 207 Argentina Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 208 Argentina Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 209 Argentina Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 210 Argentina Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 211 UAE Insomnia Market, 2018 - 2021, USD Million
  • TABLE 212 UAE Insomnia Market, 2022 - 2028, USD Million
  • TABLE 213 UAE Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 214 UAE Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 215 UAE Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 216 UAE Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 217 Saudi Arabia Insomnia Market, 2018 - 2021, USD Million
  • TABLE 218 Saudi Arabia Insomnia Market, 2022 - 2028, USD Million
  • TABLE 219 Saudi Arabia Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 220 Saudi Arabia Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 221 Saudi Arabia Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 222 Saudi Arabia Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 223 South Africa Insomnia Market, 2018 - 2021, USD Million
  • TABLE 224 South Africa Insomnia Market, 2022 - 2028, USD Million
  • TABLE 225 South Africa Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 226 South Africa Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 227 South Africa Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 228 South Africa Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 229 Nigeria Insomnia Market, 2018 - 2021, USD Million
  • TABLE 230 Nigeria Insomnia Market, 2022 - 2028, USD Million
  • TABLE 231 Nigeria Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 232 Nigeria Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 233 Nigeria Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 234 Nigeria Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 235 Rest of LAMEA Insomnia Market, 2018 - 2021, USD Million
  • TABLE 236 Rest of LAMEA Insomnia Market, 2022 - 2028, USD Million
  • TABLE 237 Rest of LAMEA Insomnia Market by Distribution Channel, 2018 - 2021, USD Million
  • TABLE 238 Rest of LAMEA Insomnia Market by Distribution Channel, 2022 - 2028, USD Million
  • TABLE 239 Rest of LAMEA Insomnia Market by Therapy Type, 2018 - 2021, USD Million
  • TABLE 240 Rest of LAMEA Insomnia Market by Therapy Type, 2022 - 2028, USD Million
  • TABLE 241 Key Information - Eisai Co., Ltd.
  • TABLE 242 Key Information - Takeda Pharmaceutical Company Limited
  • TABLE 243 Key Information - Vanda Pharmaceuticals, Inc.
  • TABLE 244 Key Information - Cadila Healthcare Ltd.
  • TABLE 245 Key Information - Sanofi S.A.
  • TABLE 246 key Information - Merck GrouP
  • TABLE 247 Key Information - Pfizer, Inc.
  • TABLE 248 key information - Viatris, Inc.
  • TABLE 249 Key Information - Currax Pharmaceuticals LLC
  • TABLE 250 Key Information - Purdue Pharma L.P.

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Global Insomnia Market share by Distribution Channel, 2021
  • FIG 3 Global Insomnia Market share by Distribution Channel, 2028
  • FIG 4 Global Insomnia Market by Distribution Channel, 2018 - 2028, USD Million
  • FIG 5 Global Insomnia Market share by Therapy Type, 2021
  • FIG 6 Global Insomnia Market share by Therapy Type, 2028
  • FIG 7 Global Insomnia Market by Therapy Type, 2018 - 2028, USD Million
  • FIG 8 Global Insomnia Market share by Region, 2021
  • FIG 9 Global Insomnia Market share by Region, 2028
  • FIG 10 Global Insomnia Market by Region, 2018 - 2028, USD Million
  • FIG 11 Recent strategies and developments: Eisai Co., Ltd.
  • FIG 12 Recent strategies and developments: Currax Pharmaceuticals LLC
目次

The Global Insomnia Market size is expected to reach $5.7 billion by 2028, rising at a market growth of 3.9% CAGR during the forecast period.

A common sleep disorder called insomnia can make it difficult to fall asleep, stay asleep, or wake up early and have trouble falling back asleep. Stress, bad sleeping habits, irregular sleep schedules, mental health conditions like physical illnesses and pain, anxiety and depression, medications, neurological issues, and specific sleep disorders are some of the common causes of insomnia.

The rise in the prevalence of distinct sleep disorders, including parasomnias as well as insomnia, and the rise in mental depression and other painful conditions, are the main factors driving the growth of the insomnia market size. Sleep issues are a result of mental depression. As a result, an increase in mental depression among the general population contributes to the growth of the insomnia market. Furthermore, taking some medications for a chronic condition over an extended period of time has some side effects that are thought to impair a patient's ability to sleep.

Additionally, the market for insomnia is expanding due to an increase in work-related stress. The increased workload and demanding work schedules result in poor sleep. Additionally, a lot of people including security guards work odd shifts, and the manufacturing sector is open around-the-clock. The quality and rhythm of sleep are impacted by these irregular work shifts. Also, a rise in the number of sleep diagnostics and centres for people with insomnia helps has been seen in the past few years. The centres for insomnia help people get better quality sleep, and the centres for sleep disorders are utilized as diagnostic testing facilities.

COVID-19 Impact Analysis

It is anticipated that the COVID-19 outbreak will benefit the expansion of the market for insomniac remedies. Due to improperly functioning industries brought on by the COVID-19 pandemic, many workers lost their jobs, which contributed to an increase in stress levels in society. Additionally, some people around the world developed depression as a result of pandemic fear. As a result, the COVID-19 pandemic's increased incidence of insomnia a condition marked by stress and depression boosts the demand for drugs that treat insomnia and propel the market's expansion.

Market Growth Factors

Increasing Aging Population

According to studies, older people (defined as those 65 and older) appear to have an 11-fold increased risk of developing some types of cancer than younger people. The burden of cancer among the elderly would then increase as the world population ages over the following 20 years. Refractive errors, cataracts, sleep issues, and hearing loss are all fairly common in older people. A large ratio of old age people is facing sleeping issues worldwide. Thus, the rise in the aging population would result in an increasing number of insomnia cases which would further support the growth of the insomnia market over the forecast period.

Increasing Healthcare Costs

Rising healthcare costs and earlier disease diagnosis because of greater awareness of treatment options are factors that are anticipated to fuel the market growth over the course of the forecast period. The increasing size and number of funds invested in the healthcare industry by governments of different countries are one of the primary drivers of the market's growth. Governments from a number of nations boosted their investments in creating healthcare systems whenever the COVID-19 pandemic first started to spread. As the pandemic's impact lessens, various hospitals are now concentrating on using these resources to treat other severe diseases. The insomnia market is expanding as a result of rising healthcare investment.

Market Restraining Factors

High Cost Of Diagnosing And Treating Insomnia

The high cost of diagnosis and treatment is one of the major factors impeding the growth of the insomnia market. Additionally, the term "sleeping problem" covers a wide range of illnesses that have significant detrimental effects on an individual's health and incur high societal costs. Insomnia makes it difficult to carry out daily tasks and is associated with a heavy financial & medical burden many patients are completely disabled. Insomnia patients spent about two times as much on direct medical care each year as matched controls without condition. The market for insomnia is not expanding because of the high cost of the medication.

Distribution Channel Outlook

By distribution channel, the insomnia market is divided into hospital, retail and others. The retail segment recorded a substantial revenue share in the insomnia market in 2021. The market in this segment is growing as a result of the wide availability of pills for treatment of sleeping disorder in various retail stores. In addition, the market is also growing due to rising awareness of consequences of diseases such as insomnia. Also, the government is supporting the medicines for condition to be marketed in such stores.

Therapy Type Outlook

Based on therapy type, the insomnia market is segmented into non-pharmacological therapy, pharmacological therapy. In 2021, the pharmacological therapy segment dominated the insomnia market with the maximum revenue share. This is due to the rising prevalence of insomnia and the growing number of major manufacturers of therapeutic drugs for insomnia. The presence of pills for insomnia treatment and sleeping pills is wide all over the world. The market is expanding in this segment as a result of a large number of market players present all over the world.

Regional Outlook

Region wise, the insomnia market is analyzed across the North America, Europe, Asia Pacific and LAMEA. In 2021, the North America region held the highest revenue share in the insomnia market. This is due to an increase in the prevalence of insomnia, a high incidence of stress at work, and a developed healthcare system, including the presence of insomnia centers in the region. Additionally, a rise in the number of patients suffering from chronic renal and kidney illnesses as well as the existence of a sizable number of insomnia clinics in this region are predicted to fuel market growth.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Currax Pharmaceuticals LLC (Currax Holdings USA LLC), Eisai Co., Ltd., Merck Group, Pfizer, Inc., Vanda Pharmaceuticals, Inc., Cadila Healthcare Ltd. (Zydus Cadila), Sanofi S.A., Viatris, Inc., Takeda Pharmaceutical Company Limited, and Purdue Pharma L.P.

Strategies deployed in Insomnia Market

Oct-2021: Currax expanded its geographical footprints in Brentwood by opening HQ in the region. This expansion aimed at expanding access to medicines, both generic and brand name.

Dec-2020: Vanda Pharmaceuticals got FDA approval for the HETLIOZ capsule & liquid formulation, the first FDA-approved medication for patients with SMS. The product would be used for the treatment of adults & children, respectively, with nighttime sleep disturbances associated with Smith-Magenis Syndrome (SMS).

Jun-2020: Sanofi expanded its geographical footprint in India. This expansion focused on producing Amaryl & Daonil tablets for blood glucose reduction, Frisium for seizures, and Stilnoct for insomnia in the region.

Jun-2020: Eisai launched DAYVIGO CIV, the in-house discovered orexin receptor antagonist. This launch would address adults with insomnia, characterized by difficulties with sleep onset and sleep maintenance.

Dec-2019: Eisai got FDA approval for DAYVIGO. Through this approval, DAYVIGO would be commercially available in 5 mg and 10 mg tablets following scheduling by the U.S. Drug Enforcement Administration (DEA), which is expected to occur within 90 days.

Sep-2019: Currax signed an agreement to acquire Nalpropion Pharmaceuticals, a biopharmaceutical company focused on the treatment of weight loss. This acquisition enables Currax to own the worldwide rights to CONTRAVE, one of the most prescribed weight-loss brand medications in the US.

Sep-2019: Takeda and Lundbeck got Labour and Welfare (MHLW) approval of Trintellix. By this approval, Trintellix would be able to provide the treatment of depression and depressed state.

Jul-2019: Zydus Cadila introduced Ramelteon tablets, USFDA-approved capsules used to treat insomnia. Ramelteon would be used in the treatment of insomnia associated with having trouble falling asleep.

Scope of the Study

Market Segments covered in the Report:

By Distribution Channel

  • Hospital
  • Retail
  • Others

By Therapy Type

  • Pharmacological
  • Non-Pharmacological

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
  • Eisai Co., Ltd.
  • Merck Group
  • Pfizer, Inc.
  • Vanda Pharmaceuticals, Inc.
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Sanofi S.A.
  • Viatris, Inc.
  • Takeda Pharmaceutical Company Limited
  • Purdue Pharma L.P.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Global Insomnia Market, by Distribution Channel
    • 1.4.2 Global Insomnia Market, by Therapy Type
    • 1.4.3 Global Insomnia Market, by Geography
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition & Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies deployed in Insomnia Market

Chapter 4. Global Insomnia Market by Distribution Channel

  • 4.1 Global Hospital Market by Region
  • 4.2 Global Retail Market by Region
  • 4.3 Global Others Market by Region

Chapter 5. Global Insomnia Market by Therapy Type

  • 5.1 Global Pharmacological Market by Region
  • 5.2 Global Non-Pharmacological Market by Region

Chapter 6. Global Insomnia Market by Region

  • 6.1 North America Insomnia Market
    • 6.1.1 North America Insomnia Market by Distribution Channel
      • 6.1.1.1 North America Hospital Market by Country
      • 6.1.1.2 North America Retail Market by Country
      • 6.1.1.3 North America Others Market by Country
    • 6.1.2 North America Insomnia Market by Therapy Type
      • 6.1.2.1 North America Pharmacological Market by Country
      • 6.1.2.2 North America Non-Pharmacological Market by Country
    • 6.1.3 North America Insomnia Market by Country
      • 6.1.3.1 US Insomnia Market
        • 6.1.3.1.1 US Insomnia Market by Distribution Channel
        • 6.1.3.1.2 US Insomnia Market by Therapy Type
      • 6.1.3.2 Canada Insomnia Market
        • 6.1.3.2.1 Canada Insomnia Market by Distribution Channel
        • 6.1.3.2.2 Canada Insomnia Market by Therapy Type
      • 6.1.3.3 Mexico Insomnia Market
        • 6.1.3.3.1 Mexico Insomnia Market by Distribution Channel
        • 6.1.3.3.2 Mexico Insomnia Market by Therapy Type
      • 6.1.3.4 Rest of North America Insomnia Market
        • 6.1.3.4.1 Rest of North America Insomnia Market by Distribution Channel
        • 6.1.3.4.2 Rest of North America Insomnia Market by Therapy Type
  • 6.2 Europe Insomnia Market
    • 6.2.1 Europe Insomnia Market by Distribution Channel
      • 6.2.1.1 Europe Hospital Market by Country
      • 6.2.1.2 Europe Retail Market by Country
      • 6.2.1.3 Europe Others Market by Country
    • 6.2.2 Europe Insomnia Market by Therapy Type
      • 6.2.2.1 Europe Pharmacological Market by Country
      • 6.2.2.2 Europe Non-Pharmacological Market by Country
    • 6.2.3 Europe Insomnia Market by Country
      • 6.2.3.1 Germany Insomnia Market
        • 6.2.3.1.1 Germany Insomnia Market by Distribution Channel
        • 6.2.3.1.2 Germany Insomnia Market by Therapy Type
      • 6.2.3.2 UK Insomnia Market
        • 6.2.3.2.1 UK Insomnia Market by Distribution Channel
        • 6.2.3.2.2 UK Insomnia Market by Therapy Type
      • 6.2.3.3 France Insomnia Market
        • 6.2.3.3.1 France Insomnia Market by Distribution Channel
        • 6.2.3.3.2 France Insomnia Market by Therapy Type
      • 6.2.3.4 Russia Insomnia Market
        • 6.2.3.4.1 Russia Insomnia Market by Distribution Channel
        • 6.2.3.4.2 Russia Insomnia Market by Therapy Type
      • 6.2.3.5 Spain Insomnia Market
        • 6.2.3.5.1 Spain Insomnia Market by Distribution Channel
        • 6.2.3.5.2 Spain Insomnia Market by Therapy Type
      • 6.2.3.6 Italy Insomnia Market
        • 6.2.3.6.1 Italy Insomnia Market by Distribution Channel
        • 6.2.3.6.2 Italy Insomnia Market by Therapy Type
      • 6.2.3.7 Rest of Europe Insomnia Market
        • 6.2.3.7.1 Rest of Europe Insomnia Market by Distribution Channel
        • 6.2.3.7.2 Rest of Europe Insomnia Market by Therapy Type
  • 6.3 Asia Pacific Insomnia Market
    • 6.3.1 Asia Pacific Insomnia Market by Distribution Channel
      • 6.3.1.1 Asia Pacific Hospital Market by Country
      • 6.3.1.2 Asia Pacific Retail Market by Country
      • 6.3.1.3 Asia Pacific Others Market by Country
    • 6.3.2 Asia Pacific Insomnia Market by Therapy Type
      • 6.3.2.1 Asia Pacific Pharmacological Market by Country
      • 6.3.2.2 Asia Pacific Non-Pharmacological Market by Country
    • 6.3.3 Asia Pacific Insomnia Market by Country
      • 6.3.3.1 China Insomnia Market
        • 6.3.3.1.1 China Insomnia Market by Distribution Channel
        • 6.3.3.1.2 China Insomnia Market by Therapy Type
      • 6.3.3.2 Japan Insomnia Market
        • 6.3.3.2.1 Japan Insomnia Market by Distribution Channel
        • 6.3.3.2.2 Japan Insomnia Market by Therapy Type
      • 6.3.3.3 India Insomnia Market
        • 6.3.3.3.1 India Insomnia Market by Distribution Channel
        • 6.3.3.3.2 India Insomnia Market by Therapy Type
      • 6.3.3.4 South Korea Insomnia Market
        • 6.3.3.4.1 South Korea Insomnia Market by Distribution Channel
        • 6.3.3.4.2 South Korea Insomnia Market by Therapy Type
      • 6.3.3.5 Singapore Insomnia Market
        • 6.3.3.5.1 Singapore Insomnia Market by Distribution Channel
        • 6.3.3.5.2 Singapore Insomnia Market by Therapy Type
      • 6.3.3.6 Malaysia Insomnia Market
        • 6.3.3.6.1 Malaysia Insomnia Market by Distribution Channel
        • 6.3.3.6.2 Malaysia Insomnia Market by Therapy Type
      • 6.3.3.7 Rest of Asia Pacific Insomnia Market
        • 6.3.3.7.1 Rest of Asia Pacific Insomnia Market by Distribution Channel
        • 6.3.3.7.2 Rest of Asia Pacific Insomnia Market by Therapy Type
  • 6.4 LAMEA Insomnia Market
    • 6.4.1 LAMEA Insomnia Market by Distribution Channel
      • 6.4.1.1 LAMEA Hospital Market by Country
      • 6.4.1.2 LAMEA Retail Market by Country
      • 6.4.1.3 LAMEA Others Market by Country
    • 6.4.2 LAMEA Insomnia Market by Therapy Type
      • 6.4.2.1 LAMEA Pharmacological Market by Country
      • 6.4.2.2 LAMEA Non-Pharmacological Market by Country
    • 6.4.3 LAMEA Insomnia Market by Country
      • 6.4.3.1 Brazil Insomnia Market
        • 6.4.3.1.1 Brazil Insomnia Market by Distribution Channel
        • 6.4.3.1.2 Brazil Insomnia Market by Therapy Type
      • 6.4.3.2 Argentina Insomnia Market
        • 6.4.3.2.1 Argentina Insomnia Market by Distribution Channel
        • 6.4.3.2.2 Argentina Insomnia Market by Therapy Type
      • 6.4.3.3 UAE Insomnia Market
        • 6.4.3.3.1 UAE Insomnia Market by Distribution Channel
        • 6.4.3.3.2 UAE Insomnia Market by Therapy Type
      • 6.4.3.4 Saudi Arabia Insomnia Market
        • 6.4.3.4.1 Saudi Arabia Insomnia Market by Distribution Channel
        • 6.4.3.4.2 Saudi Arabia Insomnia Market by Therapy Type
      • 6.4.3.5 South Africa Insomnia Market
        • 6.4.3.5.1 South Africa Insomnia Market by Distribution Channel
        • 6.4.3.5.2 South Africa Insomnia Market by Therapy Type
      • 6.4.3.6 Nigeria Insomnia Market
        • 6.4.3.6.1 Nigeria Insomnia Market by Distribution Channel
        • 6.4.3.6.2 Nigeria Insomnia Market by Therapy Type
      • 6.4.3.7 Rest of LAMEA Insomnia Market
        • 6.4.3.7.1 Rest of LAMEA Insomnia Market by Distribution Channel
        • 6.4.3.7.2 Rest of LAMEA Insomnia Market by Therapy Type

Chapter 7. Company Profiles

  • 7.1 Eisai Co., Ltd.
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental and Regional Analysis
    • 7.1.4 Research & Development Expenses
    • 7.1.5 Recent strategies and developments:
      • 7.1.5.1 Product Launches and Product Expansions:
      • 7.1.5.2 Approvals and Trails:
  • 7.2 Takeda Pharmaceutical Company Limited
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Regional Analysis
    • 7.2.4 Research & Development Expense
    • 7.2.5 Recent strategies and developments:
      • 7.2.5.1 Approvals and Trails:
  • 7.3 Vanda Pharmaceuticals, Inc.
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Research & Development Expenses
    • 7.3.4 Recent strategies and developments:
      • 7.3.4.1 Approval and Trails:
  • 7.4 Cadila Healthcare Ltd. (Zydus Cadila)
    • 7.4.1 Company Overview
    • 7.4.2 Financial Analysis
    • 7.4.3 Segmental and Regional Analysis
    • 7.4.4 Research & Development Expense
    • 7.4.5 Recent strategies and developments:
      • 7.4.5.1 Product Launches and Product Expansions:
  • 7.5 Sanofi S.A.
    • 7.5.1 Company Overview
    • 7.5.2 Financial Analysis
    • 7.5.3 Segmental and Regional Analysis
    • 7.5.4 Research & Development Expense
    • 7.5.5 Recent strategies and developments:
      • 7.5.5.1 Geographical Expansions:
  • 7.6 Merck Group
    • 7.6.1 Company Overview
    • 7.6.2 Financial Analysis
    • 7.6.3 Segmental and Regional Analysis
    • 7.6.4 Research & Development Expense
  • 7.7 Pfizer, Inc.
    • 7.7.1 Company Overview
    • 7.7.2 Financial Analysis
    • 7.7.3 Regional & Segmental Analysis
    • 7.7.4 Research & Development Expense
  • 7.8 Viatris, Inc.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Analysis
    • 7.8.3 Segmental and Regional Analysis
    • 7.8.4 Research & Development Expense
  • 7.9 Currax Pharmaceuticals LLC (Currax Holdings USA LLC)
    • 7.9.1 Company Overview
    • 7.9.2 Recent strategies and developments:
      • 7.9.2.1 Acquisition and Mergers:
      • 7.9.2.2 Geographical Expansions:
  • 7.10. Purdue Pharma L.P.
    • 7.10.1 Company Overview